<DOC>
	<DOCNO>NCT03042806</DOCNO>
	<brief_summary>Patients affect Chronic Obstructive Pulmonary Disease ( COPD ) benefit pulmonary rehabilitation term exercise capacity , symptom health-related quality life whereas effect physical activity still clear . Some study investigate effect exercise training daily physical activity . However , considerable variability study finding , data discordant effect exercise train physical activity unclear . There probably number reason account . First , choice method evaluate physical activity . Although direct observation , double-labelled water calorimetry consider gold standard assess physical activity , time consume expensive use large population study .The Physical Activity ( PA ) patient COPD assess use questionnaire . A variety questionnaire exist capture different aspect physical activity amount , type , intensity , symptom experience limitation performance `` activity daily life '' . Up , still exist instrument evaluates physical activity COPD patient Italian language take account Italian people ' lifestyle . Since strongly influence environment , cultural social condition live , essential instrument specifically tailor population study . Aim study validate Maugeri Physical Activity questionnaire ( MaPAct ) COPD patient point assess self-perceived physical activity .</brief_summary>
	<brief_title>Validation Questionnaire Physical Activity COPD : Maugeri Physical Activity Questionnaire ( MaPAct )</brief_title>
	<detailed_description>Methods The study approve Internal Review Board Ethics Committee Salvatore Maugeri Foundation , Institute Care Scientific Research Rehabilitation Tradate Lumezzane , Italy Malcantonese Hospital , Castelrotto , Switzerland . The procedure perform September 2016 September 2018 . Study design A team expert , ( 1 pulmonologist , 1 bioengineer , 4 physiotherapist , 1 psychologist 1 psychometrist ) elaborate instrument define instruction administer MaPAct self-evaluate physical activity daily life . This phase distinguish three step . Subjects A total 195 in-hospital patient ( 15 first step , 50 second step 130 third ) diagnosis COPD , enrol . Will exclude study patient hospitalize 30 day admission , patient degenerative neuromuscular disease , subject motor disability limit ambulation , subject memory comprehension problem , dementia , Parkinson disease , subject give consent participation study . All subject receive consent inform . Step 1 A focus group 15 patient arrange patient ask fill preliminary version questionnaire offer impression . In pilot step patient also ask discuss relevance study population comprehensiveness item describe generically 'clear ' 'unclear ' , `` appropriate '' `` appropriate '' ( 16-17 ) , aim achieve consensus item . Where item describe `` appropriate '' `` unclear '' , participant explain reason . Some item remove stage , reword necessary . The objective include item judge relevant COPD patient . These item form Item Set . Step 2 The patient-perceived comprehensibility test sample 50 patient . Patients ask rank perceived comprehensibility questionnaire 4-point Likert scale , 0 3 ( 0 =Easy , 1 =Quite easy , 2 = Quite difficult , 3 = Difficult ) . Some item remove stage , reword necessary . Step 3 The definitive version MaPAct administer sample 130 patient evaluate psychometric property MaPAct . A complete Rasch analysis perform , along evaluation internal consistency test-retest reliability sub-sample subject . Finally , since skeletal muscle weakness , reduce exercise capacity , slow gait reduce physical activity level well-known systemic effect COPD , order estimate MaPAct criterion validity COPD status , correlation MaPAct Global Initiative Chronic Obstructive Lung Disease ( GOLD ) stage ( 18 ) , hospital admission exacerbation define GOLD symptom derive mMRC CAT scale evaluate . Time complete MaPAct also assess . In order provide estimate reliability MaPAct describe objective physical activity , sub group 30 patient metabolic holter ( SenseWear armband - 48 hour ) use measure daily calorie , number step Metabolic Equivalents ( METS ) correlate MapAct . Timeline On day 1 study , COPD patient perform medical evaluation ( medical history , physical examination history COPD exacerbation within 12 month ) , pulmonary function test , blood gas analysis MaPAct . On subsequent day , 40 consecutive patient complete MaPAct ( + 24 h ) intrarater variability determination , subject perform 6-minute walk test ( 6MWT ) evaluate perceive exertion ( CR-10 ; modify Borg Scale ; 19 ) . In subject modify Medical Research Council- ( mMRC Dyspnea Index ; 20 , 21 ) , COPD Assessment Test ( CAT , 22 ) carry . The GOLD spirometric classification use determine severity disease : mild COPD , force expiratory volume one second ( FEV1 ) ≥80 % predict ; moderate COPD , 50 % ≤FEV1 &lt; 80 % predict ; severe-to-very severe COPD , FEV1 &lt; 50 % predict . Statistical analysis Internal consistency The internal consistency MaPAct assess calculating : 1 . Cronbach 's coefficient alpha : closer 1.0 great internal consistency item scale . An alpha 0.8 reasonable goal . Rules thumb : `` Alpha &gt; 0.9 Excellent ; &gt; 0.8 Good ; &gt; 0.7 Acceptable '' ( 23 ) ; 2 . Item-remainder correlation Spearman 's rank correlation ( ρ ) coefficient examine correlation item sum remain item , omit item total : Spearman coefficient ρ &gt; 0.40 consider minimum value satisfactory item-to-total correlation ( 24 ) . Reproducibility Reliability coefficient estimate intraclass correlation coefficient ( ICC ) . Expecting obtain ICC value .90 , 95 % confidence interval ( CI ) .20 , least 32 subject require ( 25 ) . Rasch Analysis For Rasch analysis , sample size 100 person estimate item difficulty alpha 0.05 within ± 0.5 logits ( 26 ) . The step analysis follow : 1 . Rating scale diagnostic . We investigate whether rating scale use expected manner . We evaluate response category suggest Linacre ( 27 ) . 2 . Validity , assess evaluate goodness fit real data model data , test item fit model expectation . We consider mean-square ( MnSq ) &gt; 0.7 &lt; 1.3 indicator acceptable fit ( 28 ) . Items outside range consider underacting ( MnSq &gt; 1.3 , suggest presence unexpectedly high variability ) , overfitting ( MnSq &lt; 0.7 , indicate predictable pattern ) . 3 . Reliability , evaluate term separation , define ratio person ( item ) `` true '' standard deviation error standard deviation ( 29 ) . Item separation use verify item hierarchy reflect number `` strata '' measure statistically discernible . A separation 2.0 consider good sufficient allow stratification 3 group ( 30 ) . A related index reliability separation index , provide degree confidence place reproducibility estimate ; value coefficient vary 0 1 ( value &gt; 0.80 consider good , &gt; 0.90 excellent ) ( 31 ) . 4 . Principal component analysis ( PCA ) standardize residual use investigate : 4.1 . The dimensionality scale . In case `` unidimensionality '' assumes , removal trait scale intend measure ( `` Rasch factor '' ) , residual uncorrelated normally distribute ( i.e . principal component ) . The following criterion use determine whether additional factor likely present residual : least 50 % variance explain Rasch factor , eigenvalue first contrast small 3 , variance explain contrast small 5 % . 4.2 . The local independence item . High correlation ( &gt; 0.30 ) residual 2 item indicate may locally independent subsidiary dimension measurement account main Rasch dimension ( 32 ) . Criterion validity Spearman 's rank correlation ( ρ ) coefficient use examine correlation MaPAct COPD status indicate GOLD stage , CAT mMRC score . The effect size correlation expect medium high ( r ~ 0.4 ) . In order detect departure hypothesis ( i.e . small effect size , r &lt; = .2 ) , sample size require 130 subject ( alpha = 0.05 , beta = 0.8 , one side test ) . Comparison Objective Physical Activity Spearman 's rank correlation ( ρ ) coefficient use examine correlation MaPAct daily calorie , number step METS measure metabolic holter :</detailed_description>
	<criteria>COPD diagnosis stable state , able read write , accept sign inform consent exclude patient hospitalize 30 day evaluation , patient degenerative neuromuscular disease , subject motor disability limit deambulation , subject memory comprehension problem , dementia , parkinson disease , cognitive impairment , subject give consent participation study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Physical Activity</keyword>
	<keyword>Questionnaire</keyword>
</DOC>